Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
1.
Boll Soc Ital Biol Sper ; 70(8-9): 235-42, 1994.
Article in English | MEDLINE | ID: mdl-7893482

ABSTRACT

Increased levels of circulating immunecomplexes (CIC) have been demonstrated in the serum of patients with HBV infection and HDV superinfection. This finding appears to be correlated to the disease's activity. In this report serum levels of two fractions of CIC (CIC-Clq and CIC-C3d) were evaluated by ELISA method in a sample of 110 subjects with hepatitis infection (HBV, HCV, HDV). Reference values were obtained in a group of 45 healthy subjects (blood donors). Both the CIC fractions were increased in the patients with HCV infection. The most significant increase for both CIC-C1q and CIC-C3d was found in the cirrhotic patients. The complement fractions C3c and C4 were determined in the serum of these patients to investigate a potential pathogenic role of such immunecomplexes. C3c and C4 fractions showed a significant decrease only in the cirrhotic patients, without correlation with the viral agent. Serum levels of C1q complement fraction were not significantly decreased, thus excluding an impaired synthesis of complement fractions. No significant correlation was found between CIC and C3c and C4 fractions in patients with increased levels of CIC, except a slightly significant correlation between reduction of C3c and increase of CIC-C1q. These data suggest a pathogenic action of immunecomplexes in the course of HCV, particularly in the cirrhotic stage.


Subject(s)
Antigen-Antibody Complex/blood , Complement System Proteins/metabolism , Hepatitis B/immunology , Hepatitis C/immunology , Hepatitis D/immunology , Adult , Aged , Antigen-Antibody Complex/immunology , Complement C1q/metabolism , Complement C3c/metabolism , Complement C4/metabolism , Female , Hepatitis Antibodies/blood , Hepatitis Antibodies/immunology , Humans , Male , Middle Aged , Prevalence
2.
Minerva Med ; 84(11): 633-6, 1993 Nov.
Article in Italian | MEDLINE | ID: mdl-8015692

ABSTRACT

The onset of Acquired Immunodeficiency Syndrome (AIDS) is often characterized by a variety of symptoms, with the involvement of several tissues and organs. In the present case a polyarthritic syndrome was the symptomatology at the onset. Clinical onset. A 26 year old man, drug abuser, anti HIV positive, with a CD4/CD8 ratio = 0.8, was observed in January 1990. He presented polyarthritic involvement of the ankles and right knee, conjunctivitis and successfully keratodermia. The diagnosis of Reiter syndrome was made on the basis of the clinical features and laboratory findings (Chlamydia in his urethral secretion). The patient did not denote any symptom of immunodeficiency, except small lymphonodal painless swelling in axillary and latero-cervical region. A significant clinical improvement was obtained with chlortetracycline at a dosage of 100 mg daily and 6 methylprednisolone 12 mg daily. Comment. This experience suggests the importance and the usefulness of the anti HIV test in patients affected by a reactive arthritis, as the Reiter's syndrome, since the progressive diffusion of the HIV infection.


Subject(s)
Arthritis, Reactive/microbiology , HIV Infections/complications , Adult , Humans , Male
3.
J Endocrinol Invest ; 16(8): 619-24, 1993 Sep.
Article in English | MEDLINE | ID: mdl-8258650

ABSTRACT

Gonadal sex hormones may account for the sexual dimorphism in the immune response and for the greater incidence of autoimmune disease in females. We have previously reported the presence of progesterone (P) deficiency in female patients with thyroid and ovarian autoimmune disease. In this context, the hormonal profile in 9 women with rheumatoid arthritis (RA) and in 9 age-matched ealthy women, were evaluated to verify the presence of a steroid hormone secretion impairment in a systemic autoimmune disease, further supporting our hypothesis of P deficiency involvement. P and androgen plasma levels, in the luteal phase, were significantly lower (p < 0.05 and 0.005, respectively) in RA patients than in the control group, with a consequent decrease of the free androgen index. Moreover, despite normal cortisol values, corticosterone (B) plasma levels were significantly higher in the RA patients (p < 0.01 and 0.05 in follicular and luteal phase, respectively). Therefore, our present data confirm the androgen deficiency in patients with a systemic autoimmune disease, such as RA and support the immunomodulator effect of P. Finally, the higher B plasma levels in RA patients may suggest the presence of a slight impairment of the immune hypothalamic-pituitary-adrenal axis (HPAA), supporting its role in certain phases of RA pathogenesis. In conclusion, in addition to androgens, the immunomodulator role of P should also be taken into account in the pathogenesis of the systemic autoimmune disease.


Subject(s)
Arthritis, Rheumatoid/blood , Hormones/blood , Adult , Androgens/deficiency , Corticosterone/blood , Female , Follicular Phase/physiology , Humans , Luteal Phase/physiology , Progesterone/blood
4.
Boll Soc Ital Biol Sper ; 69(3): 203-8, 1993 Mar.
Article in English | MEDLINE | ID: mdl-8129899

ABSTRACT

The presence of anti-platelet autoantibodies has been reported in many cases of HIV infection, but there is no accordance about their pathogenic role in the onset of thrombocytopenia in the patients studied. In the present study surface anti-platelet antibodies (PAIgG) and serum anti-platelet antibodies (sPAIgG) were assayed in a group of 135 HIV-infected patients (109 men, 26 women), in different clinical stages by using an immunofluorescence test (PSIFT). In order to investigate the possible correlation of the positivity of these autoantibodies and the onset of thrombocytopenia, some of these patients were controlled in a follow-up study, with two successful controls: 10 months (II control: 89 patients) and 20 months (III control: 59 patients) after the first time. In the I control PAIgG were positive in 68 subjects (50.4%) and sPAIgG in 34 (25.2%); both PAIgG and sPAIgG were present in 23 patients (17%). 56 patients did not present anti-plt antibodies (41.5%). No significantly different distribution of these autoantibodies in each stage of disease was observed. The mean value of platelet count resulted in the normal range both in the anti-plt antibody positive and in the anti-plt antibody negative patients, but the value found in the anti-plt antibody positive patients was significantly lower than the one found in the anti-plt antibody negative group (p < 0.01). This difference was more marked between the group with PAIgG and anti-plt antibody negative patients than between the group with sPAIgG and the anti-plt antibody negative patients (p < 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Autoantibodies/blood , Blood Platelets/immunology , HIV Infections/complications , Thrombocytopenia/complications , Adolescent , Adult , Antibody Specificity , Autoantibodies/biosynthesis , Autoantibodies/immunology , Child , Female , Follow-Up Studies , HIV Infections/blood , HIV Infections/immunology , Humans , Male , Middle Aged , Thrombocytopenia/immunology
5.
Invest Ophthalmol Vis Sci ; 26(9): 1306-9, 1985 Sep.
Article in English | MEDLINE | ID: mdl-3875590

ABSTRACT

Flow cytometry (FCM) was used to investigate antigenic expression and modulation during the cell cycle of Y-79 and WERI-Rb1 tissue cultured retinoblastoma cell lines using a polyclonal anti-Y-79 antibody and fluorescein conjugated lectins. Several Y-79 resting cell populations were identified by FCM analysis of antibody binding, while only a single population with uniform antigen expression was found to exist in the synthetic and mitotic phases. WERI-Rb1 cells bound antibody approximately equally in each phase of the cell cycle. Multiple cell populations with different lectin binding affinities were seen in the resting phase with FITC-concanavalin A, FITC-ricinus communis-60 and FITC-ricinus communis-120 (FITC-RCA-120). During the S-phase of the cell cycle, a higher percentage of cells bound FITC-RCA-120 and FITC wheat germ agglutinin. The relationship between antigenic expression during the cell cycle and treatment considerations in retinoblastoma is discussed.


Subject(s)
Antigens, Surface/immunology , Eye Neoplasms/immunology , Retinoblastoma/immunology , Antibodies, Anti-Idiotypic/immunology , Antigens/immunology , Arrestin , Cell Cycle , Cell Line , Eye Neoplasms/analysis , Flow Cytometry , Lectins/immunology , Retinoblastoma/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...